El Futuro en el Tratamiento del Cáncer Renal - page 22

MEDI0680 plus Durvalumab in a phase I trial
Hamid O, et al. ESMO 2016
1...,12,13,14,15,16,17,18,19,20,21 23,24,25,26,27,28,29,30,31,32,...36
Powered by FlippingBook